Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depo-Medrol vs Kenalog for shoulder injection flare reactions
NCT05438277Phase 4Completed
- Sponsor
- Campbell Clinic Orthopaedics
- Start
- Jan 2020
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone in shoulder pain (2 arms), sponsored by Campbell Clinic Orthopaedics. Primary endpoint: Incidence of a Flare Reaction at 7 days. Started Jan 2020; status: completed.
02
Drugs
methylprednisolone
03
Conditions
shoulder pain
Beyond the preview
Go deeper on NCT05438277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05438277.